Aktie A2PED5 AVEDRO, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Avedro, Inc.

Aktien

A2PED5

US05355N1090

AVDR

Verzögert Nasdaq
Andere Börsenplätze
 		% 5 Tage % 1. Jan.
- USD -.--% Intraday Chart für Avedro, Inc. +0,61 % -.--%
2019 Avedro, Inc. gibt ungeprüfte Ergebniszahlen für das zweite Quartal und die sechs Monate bis zum 30. Juni 2019 bekannt; revidiert Umsatzprognose für das Gesamtjahr 2019 CI
2019 Transcript : Avedro, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 05:15 PM

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
INVESTIGATION ALERT: Nationally Ranked Litigation Firm Labaton Sucharow Announces Investigation of the Merger of Avedro, Inc. and Glaukos Corporation and Strongly Encourages Investors to Contact the Firm
INVESTIGATION ALERT: Nationally Ranked Litigation Firm Labaton Sucharow Announces Investigation of the Merger of Avedro, Inc. and Glaukos Corporation and Strongly Encourages Investors to Contact the Firm
Avedro, Inc.(NasdaqGM:AVDR) dropped from S&P TMI Index
AVEDRO INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
Avedro, Inc. Announces Board Changes
Avedro, Inc.(NasdaqGM:AVDR) dropped from NASDAQ Composite Index
Glaukos Corporation completed the acquisition of Avedro, Inc. from a group of sellers.
AVEDRO INC : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
Avedro, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
Avedro, Inc. Announces Third Quarter 2019 Financial Results
Avedro Announces Schedule of Events at the American Academy of Ophthalmology Annual Meeting
Boost Epi-On™ Corneal Cross-Linking Data to Be Presented at the 37th Congress of the ESCRS
AVEDRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avedro, Inc. - AVDR
Certain Common Stock of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.
Certain Options of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.
Certain Warrants of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.
Certain Restricted Stock Units of Avedro, Inc. are subject to a Lock-Up Agreement Ending on 13-AUG-2019.
Avedro, Inc. Announces Resignation of Thomas W. Burns and Gilbert H. Kliman from the Board of Directors
Avedro, Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2019; Revises Revenue Guidance for the Full Year of Fiscal 2019
Avedro, Inc. Announces Second Quarter 2019 Financial Results
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PED5 Aktie
  4. Nachrichten Avedro, Inc.
  5. Andere Sprachen